Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme

Expert Review of Anticancer Therapy

Volumn 9, Issue 11, 2009, Pages 1643-1650

  Wilson, Roa ^a   Xing, James Z ^a   Small, Cormac ^b   Kortmann, Rolf ^c   Miriamanoff, Rene ^d   Okunieff, Paul ^e   Shibamoto, Yuta ^f   Jeremic, Branislav ^g  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^g INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

Author keywords

Chemotherapy; Elderly; Glioblastoma; Hypofractionated radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ANEMIA; BLOOD TOXICITY; BRAIN METASTASIS; CANCER CONTROL; CANCER GRADING; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DRUG DOSE INCREASE; DRUG ERUPTION; DRUG WITHDRAWAL; ELDERLY CARE; FATIGUE; FRAIL ELDERLY; GLIOBLASTOMA; HUMAN; LIFE EXPECTANCY; MORBIDITY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PATIENT SAFETY; PNEUMONIA; POSTOPERATIVE CARE; PROGNOSIS; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; REFERENCE VALUE; REVIEW; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT DURATION;

AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DACARBAZINE; FRAIL ELDERLY; GLIOBLASTOMA; HUMANS; QUALITY OF LIFE; RADIOTHERAPY DOSAGE;

EID: 71949106203     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/ERA.09.128     Document Type: Review

References (45)

1. McLendon R, Halperin E. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? Cancer 98, 1745-1748 (2003). (Pubitemid 37238632)
2. Stupp R, Mason W, van den Bent M et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987-996 (2005). (Pubitemid 40349501)
3. Surawicz T, Davis F, Freels S, Laws ER Jr, Menck HR. Brain tumor survival: results from the national cancer data base. J. Neurooncol. 40, 151-160 (1998). (Pubitemid 29010168)
4. Tait M, Petrik V, Loosemore A, Bell BA, Papadopoabs MC. Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases. Br. J. Neurosurg. 21, 496-500 (2007).
5. Curran WJ Jr, Scott CB, Horton J et al. Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J. Natl Cancer Inst. 85, 704-710 (1993). (Pubitemid 23133591)
6. Wrensch M, Minn Y, Chew T et al. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 4, 278-299 (2002).
7. Hess K, Broglio K, Bondy M. Adult glioma incidence trends in the United States, 1977-2000. Cancer 101, 2293-2299 (2002).
8. Combs SE, Wagner J, Bischof M et al. Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Int. J. Radiat. Oncol. Biol. Phys. 70, 987-992 (2008) (Pubitemid 351296114)
9. Sijben AE, McIntyre JB, Roldán GB et al. Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme. J. Neurooncol. 89, 97-103 (2008)
10. Minniti G, Sanctis V, Muni R et al. Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma. J. Neurooncol. 91, 95-100 (2009).
11. Clark, J, Chang, E, Levin V et al. Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients. Expert Rev. Anticancer Ther. 8(5), 733-741 (2008).
12. Chang E, Yi W, Allen P et al. Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors. Int. J. Radiat. Oncol. Biol. Phys. 56(2), 519-528 (2003). (Pubitemid 36542912)
13. Mohan D, Suh J, Phan J et al. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int. J. Radiat. Oncol. Biol. Phys. 42, 981-987 (1998). (Pubitemid 29004138)
14. Kirkbride P, Tannock IF. Trials in palliative treatment - have the goal posts been moved? Lancet Oncol. 9, 186-187 (2008). (Pubitemid 351722934)
15. Mauer ME, Bottomley A, Collette L, Slotman BJ. Palliative-care trials: how best to publish findings? Lancet Oncol. 9, 411-412 (2008). (Pubitemid 351597792)
16. Wong J, Hird A, Kirou-Mauro A et al. Quality of life in brain metastases radiation trials: a literature review. Curr. Oncol. 15, 25-45 (2008).
17. Weitzner M, Meyers C, Gelke C et al. The functional assessment of cancer therapy (FACT) scale: development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumours. Cancer 75, 1151-1161 (1995).
18. Hutchins L, Unger J, Crowley J et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N. Engl. J. Med. 341, 2061-2067 (1999). (Pubitemid 30035956)
19. Lewis J, Kilgore M, Goldman D et al. Participation of patients 65 years of age or older in cancer clinical trials. J. Clin. Oncol. 21, 1383-1389 (2003). (Pubitemid 46606420)
20. Iwamoto F, Reiner A, Panageas K et al. Patterns of care in elderly glioblastoma patients. Ann. Neurol. 64, 628-634 (2008).
21. Villa S, Vinolas N, Verger E et al. Efficacy of radiotherapy for malignant gliomas in elderly patients. Int. J. Radiat. Oncol. Biol. Phys. 42(5), 977-980 (1998). (Pubitemid 29004137)
22. McAleese J, Stenning S, Ashley S et al. Hypofractionated radiotherapy for poor prognosis malignant glioma: matched pair survival analysis with MRC controls. Radiother. Oncol. 67, 177-182 (2003). (Pubitemid 36695096)
23. Keime-Guibert F, Chinot O, Taillandier L et al. Radiotherapy for glioblastoma in the elderly. N. Engl. J. Med. 356, 1527-1537 (2007).
24. Roa W, Brasher P, Bauman G et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J. Clin. Oncol. 22, 1583-1588 (2004). (Pubitemid 41079795)
25. Lutterbach J, Ostertag C. What is the appropriate radiotherapy protocol for older patients with newly diagnosed glioblastoma? J. Clin. Oncol. 23, 2869-2870 (2005). (Pubitemid 46179485)
26. Hulshof M, Schimmel E, Andries Bosch D et al. Hypofractionation in glioblastoma multiforme. Radiother. Oncol. 54, 143-148 (2000).
27. Chinot O, Barrie M, Frauger E et al. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly population. Cancer 100, 2208-2214 (2004). (Pubitemid 38580342)
28. Glantz M, Chamberlain M, Liu Q et al. Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas. Cancer 97(9), 2262-2266 (2003). (Pubitemid 36444070)
29. Brandes A, Vastola F, Basso U et al. A prospective study on glioblastoma in the elderly. Cancer 97, 657-662 (2003).
30. Brandes A, Franceschi E, Tosoni A et al. Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. Cancer 115, 3512-3518 (2009).
31. Jones B, Sanghera P. Estimation of radiobiologic parameters and equivalent radiation dose of cytotoxic chemotherapy in malignant glioma. Int. J. Radiat. Oncol. Biol. Phys. 68, 441-448 (2007). (Pubitemid 46694163)
32. Jones S. Cancer in the developing world: a call to action. BMJ 319, 505-508 (1999). (Pubitemid 29391364)
33. Van Der Giessen P, Alert J, Badri C et al. Multinational assessment of some operational costs of teletherapy. Radiother. Oncol. 71, 347-355 (2004). (Pubitemid 38686674)
34. Levin C, El Gueddari B, Meghzifene A. Radiation therapy in Africa: distribution and equipment. Radiother. Oncol. 52, 79-84 (1999). (Pubitemid 29461100)
35. Barton M, Frommer M, Shafiq J. Role of radiotherapy in cancer control in low-income and middle-income countries. Lancet Oncol. 7, 584-595 (2006). (Pubitemid 43923676)
36. Zubizarreta E, Poitevin A, Levin C. Overview of radiotherapy resources in Latin America: a survey by the international atomic energy agency (IAEA). Radiother. Oncol. 73, 97-100 (2004). (Pubitemid 39304131)
37. Tatsuzaki H, Levin C. Quantitative status of resources for radiation therapy in Asia and Pacific region. Radiother. Oncol. 60, 81-89 (2001). (Pubitemid 32532085)
38. Hoegler D, Davey P. A prospective study of short course radiotherapy in elderly patients with malignant glioma. J. Neurooncol. 33, 201-204 (1997). (Pubitemid 27241308)
39. Newall J, Ransohoff J, Kaplan B. Glioblastoma in the older patient: how long a course of radiotherapy is necessary? J. Neurooncol. 6, 325-327 (1988). (Pubitemid 19032430)
40. Slotman B, Kralendonk J, van Alphen H et al. Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors. Int. J. Radiat. Oncol. Biol. Phys. 34, 895-898 (1996). (Pubitemid 26089228)
41. Jeremic B, Shibamoto Y, Grujicic D et al. Short-course radiotherapy in elderly and frail patients with glioblastoma multiforme. A Phase II study. J. Neurooncol. 44, 85-90 (1999). (Pubitemid 29515655)
42. Idbaih A, Taillibert S, Simon J et al. Short course of radiation therapy in elderly patients with glioblastoma multiforme. Cancer Radiother. 12, 788-792 (2008).
43. Ford J, Stenning S, Boote D et al. A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma. Clin. Oncol. (R. Coll. Radiol.) 9, 20-24 (1997). (Pubitemid 27135663)
44. Bauman G, Gaspar L, Fisher B et al. A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 29, 835-839 (1994). (Pubitemid 24241325)
45. Central Brain Tumor Registry of the United States, Primary brain tumors in the United States statistical report 2000-2004 www.cbtrus.org/reports//2007- 2008/2007report.pdf